GeynismanDM: Anti-programmed cell death protein 1 (PD-1) antibody nivolumab leads to a dramatic and rapid response in papillary renal cell carcinoma with sarcomatoid and rhabdoid features. Eur Urol, 2015; 68:912–914.
2.
BackAL, ArnoldRM, QuillTE: Hope for the best, and prepare for the worst. Ann Intern Med, 2003; 138:439–443.
3.
TemelJS, ShawAT, GreerJA: Challenge of prognostic uncertainty in the modern era of cancer therapeutics. J Clin Oncol, 2016 [Epub ahead of print; DOI: 10.1200/JCO.2016.67.8573].
